Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03692143

Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP

Sponsor: Nanfang Hospital, Southern Medical University

View on ClinicalTrials.gov

Summary

This study aimed to compare teriparatide treatments and PVPs, focusing on its effects on life qualities and effect/coast ratio and evaluate which method is better for patients.

Official title: Effect and Cost Comparation of Different Treatment Strategies for Osteoporotic Vertebral Fractures (OVF): Teriparatide Injection and Percutaneous Vertebroplasty (PVP)

Key Details

Gender

FEMALE

Age Range

49 Years - 99 Years

Study Type

OBSERVATIONAL

Enrollment

90

Start Date

2017-01-01

Completion Date

2030-12-01

Last Updated

2018-10-02

Healthy Volunteers

No

Interventions

DRUG

Teriparatide

subcutaneous injection of teriparatide(20 mg) once daily

PROCEDURE

PVP

With local anesthesia, bone cement was injected in to fractured body in a needle that penetrated transpedically and percutaneously

DRUG

Alendronate

Alendronate Sodium, oral, 70mg, once a week